Alekss / Fotolia
Genetic engineering
Check carefully, approve safely.
The release of genetically modified organisms (GMO) for scientific trials needs to be approved by the BVL. If GMO are to be cultivated commercially, the BVL will provide a statement in the Community approval process of the EU. Furthermore, the BVL manages the international information exchange on GMO in the Biosafety Clearing House for Germany. The BVL hosts the secretary of the Central Committee on Biological Safety (ZKBS). The ZKBS advises the Federal Government and the Federal States in safety-relevant questions on genetic engineering.
Many topics, one goal
The Cartagena Protocol and the Biosafety Clearing-House
The Cartagena Protocol is an international agreement that aims to contribute ensuring an adequate level of protection in the field of safe transboundary movement (transport) of GMOs to protect the biological diversity and human health. A key element …
Central Committee on Biological Safety
The Central Committee on Biological Safety (ZKBS) is a voluntary expert panel which carries out the task of assessing both the safety of genetic engineering operations and facilities as well as the safety of the release and placing on the market of …